206 related articles for article (PubMed ID: 30343119)
21. Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection.
Pasquevich KA; Estein SM; García Samartino C; Zwerdling A; Coria LM; Barrionuevo P; Fossati CA; Giambartolomei GH; Cassataro J
Infect Immun; 2009 Jan; 77(1):436-45. PubMed ID: 18981242
[TBL] [Abstract][Full Text] [Related]
22. Improved influenza viral vector based Brucella abortus vaccine induces robust B and T-cell responses and protection against Brucella melitensis infection in pregnant sheep and goats.
Mailybayeva A; Yespembetov B; Ryskeldinova S; Zinina N; Sansyzbay A; Renukaradhya GJ; Petrovsky N; Tabynov K
PLoS One; 2017; 12(10):e0186484. PubMed ID: 29023541
[TBL] [Abstract][Full Text] [Related]
23. Protective immunity elicited by a divalent DNA vaccine encoding both the L7/L12 and Omp16 genes of Brucella abortus in BALB/c mice.
Luo D; Ni B; Li P; Shi W; Zhang S; Han Y; Mao L; He Y; Wu Y; Wang X
Infect Immun; 2006 May; 74(5):2734-41. PubMed ID: 16622210
[TBL] [Abstract][Full Text] [Related]
24. Escheriosome-mediated delivery of recombinant ribosomal L7/L12 protein confers protection against murine brucellosis.
Mallick AI; Singha H; Khan S; Anwar T; Ansari MA; Khalid R; Chaudhuri P; Owais M
Vaccine; 2007 Nov; 25(46):7873-84. PubMed ID: 17931756
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of immunogenicity of novel multi-epitope subunit vaccines in combination with poly I:C against Brucella melitensis and Brucella abortus infection.
Sadeghi Z; Fasihi-Ramandi M; Bouzari S
Int Immunopharmacol; 2019 Oct; 75():105829. PubMed ID: 31437796
[TBL] [Abstract][Full Text] [Related]
26. Immune responses of mice to vaccinia virus recombinants expressing either Listeria monocytogenes partial listeriolysin or Brucella abortus ribosomal L7/L12 protein.
Baloglu S; Boyle SM; Vemulapalli R; Sriranganathan N; Schurig GG; Toth TE
Vet Microbiol; 2005 Aug; 109(1-2):11-7. PubMed ID: 15941627
[TBL] [Abstract][Full Text] [Related]
27. Subcutaneous immunization with a novel immunogenic candidate (urease) confers protection against Brucella abortus and Brucella melitensis infections.
Abkar M; Amani J; Sahebghadam Lotfi A; Nikbakht Brujeni G; Alamian S; Kamali M
APMIS; 2015 Aug; 123(8):667-75. PubMed ID: 25939375
[TBL] [Abstract][Full Text] [Related]
28. Live vaccine consisting of attenuated Salmonella secreting and delivering Brucella ribosomal protein L7/L12 induces humoral and cellular immune responses and protects mice against virulent Brucella abortus 544 challenge.
Senevirathne A; Hewawaduge C; Lee JH
Vet Res; 2020 Jan; 51(1):6. PubMed ID: 31973749
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of the efficacy of outer membrane protein 31 vaccine formulations for protection against Brucella canis in BALB/c mice.
Clausse M; Díaz AG; Ibañez AE; Cassataro J; Giambartolomei GH; Estein SM
Clin Vaccine Immunol; 2014 Dec; 21(12):1689-94. PubMed ID: 25339409
[TBL] [Abstract][Full Text] [Related]
30. Non-infectious outer membrane vesicles derived from Brucella abortus S19Δper as an alternative acellular vaccine protects mice against virulent challenge.
Solanki KS; Varshney R; Qureshi S; Thomas P; Singh R; Agrawal A; Chaudhuri P
Int Immunopharmacol; 2021 Jan; 90():107148. PubMed ID: 33189614
[TBL] [Abstract][Full Text] [Related]
31. Intraperitoneal administration of a novel chimeric immunogen (rOP) elicits IFN-γ and IL-12p70 protective immune response in BALB/c mice against virulent Brucella.
Tadepalli G; Konduru B; Murali HS; Batra HV
Immunol Lett; 2017 Dec; 192():79-87. PubMed ID: 29106986
[TBL] [Abstract][Full Text] [Related]
32. A comparison between adjuvant and delivering functions of calcium phosphate, aluminum hydroxide and chitosan nanoparticles, using a model protein of Brucella melitensis Omp31.
Abkar M; Alamian S; Sattarahmady N
Immunol Lett; 2019 Mar; 207():28-35. PubMed ID: 30707922
[TBL] [Abstract][Full Text] [Related]
33. Vaccination with Brucella recombinant DnaK and SurA proteins induces protection against Brucella abortus infection in BALB/c mice.
Delpino MV; Estein SM; Fossati CA; Baldi PC; Cassataro J
Vaccine; 2007 Sep; 25(37-38):6721-9. PubMed ID: 17686554
[TBL] [Abstract][Full Text] [Related]
34. Brucella lumazine synthase elicits a mixed Th1-Th2 immune response and reduces infection in mice challenged with Brucella abortus 544 independently of the adjuvant formulation used.
Velikovsky CA; Goldbaum FA; Cassataro J; Estein S; Bowden RA; Bruno L; Fossati CA; Giambartolomei GH
Infect Immun; 2003 Oct; 71(10):5750-5. PubMed ID: 14500496
[TBL] [Abstract][Full Text] [Related]
35. Protection of mice from Brucella infection by immunization with attenuated Salmonella enterica serovar typhimurium expressing A L7/L12 and BLS fusion antigen of Brucella.
Zhao Z; Li M; Luo D; Xing L; Wu S; Duan Y; Yang P; Wang X
Vaccine; 2009 Aug; 27(38):5214-9. PubMed ID: 19596411
[TBL] [Abstract][Full Text] [Related]
36. The recombinant Omp31 from Brucella melitensis alone or associated with rough lipopolysaccharide induces protection against Brucella ovis infection in BALB/c mice.
Estein SM; Cassataro J; Vizcaíno N; Zygmunt MS; Cloeckaert A; Bowden RA
Microbes Infect; 2003 Feb; 5(2):85-93. PubMed ID: 12650766
[TBL] [Abstract][Full Text] [Related]
37. Liposomised recombinant ribosomal L7/L12 protein protects BALB/c mice against Brucella abortus 544 infection.
Mallick AI; Singha H; Chaudhuri P; Nadeem A; Khan SA; Dar KA; Owais M
Vaccine; 2007 May; 25(18):3692-704. PubMed ID: 17296251
[TBL] [Abstract][Full Text] [Related]
38. Recombinant L7/L12 protein entrapping PLGA (poly lactide-co-glycolide) micro particles protect BALB/c mice against the virulent B. abortus 544 infection.
Singh D; Goel D; Bhatnagar R
Vaccine; 2015 Jun; 33(24):2786-92. PubMed ID: 25930114
[TBL] [Abstract][Full Text] [Related]
39. Immunization of Mice with Recombinant Brucella abortus Organic Hydroperoxide Resistance (Ohr) Protein Protects Against a Virulent Brucella abortus 544 Infection.
Hop HT; Reyes AW; Simborio HL; Arayan LT; Min WG; Lee HJ; Lee JJ; Chang HH; Kim S
J Microbiol Biotechnol; 2016 Jan; 26(1):190-6. PubMed ID: 26464379
[TBL] [Abstract][Full Text] [Related]
40. Study of serum bactericidal and splenic activity of Total-OMP- CagA combination from Brucella abortus and Helicobacter pylori in BALB/c mouse model.
Abadi AH; Mahdavi M; Khaledi A; Esmaeili SA; Esmaeili D; Sahebkar A
Microb Pathog; 2018 Aug; 121():100-105. PubMed ID: 29709690
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
